FI934751A - Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner - Google Patents

Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner Download PDF

Info

Publication number
FI934751A
FI934751A FI934751A FI934751A FI934751A FI 934751 A FI934751 A FI 934751A FI 934751 A FI934751 A FI 934751A FI 934751 A FI934751 A FI 934751A FI 934751 A FI934751 A FI 934751A
Authority
FI
Finland
Prior art keywords
modulated
extracellular matrix
receptor ligand
leukocyte function
matrix receptor
Prior art date
Application number
FI934751A
Other languages
English (en)
Other versions
FI934751A0 (fi
Inventor
Alejandro A Aruffo
N Jan Chalupny
John Marken
Jeffrey A Ledbetter
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI934751A0 publication Critical patent/FI934751A0/fi
Publication of FI934751A publication Critical patent/FI934751A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
FI934751A 1992-10-30 1993-10-27 Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner FI934751A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96970092A 1992-10-30 1992-10-30

Publications (2)

Publication Number Publication Date
FI934751A0 FI934751A0 (fi) 1993-10-27
FI934751A true FI934751A (fi) 1994-05-01

Family

ID=25515876

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934751A FI934751A (fi) 1992-10-30 1993-10-27 Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner

Country Status (8)

Country Link
EP (1) EP0595659A3 (fi)
JP (1) JPH072899A (fi)
AU (1) AU5034493A (fi)
CA (1) CA2109398A1 (fi)
FI (1) FI934751A (fi)
IL (1) IL107432A0 (fi)
MX (1) MX9306682A (fi)
NO (1) NO933860L (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405270B2 (en) 1991-10-25 2008-07-29 Immunex Corporation CD40-Ligand lacking native-pattern glycosylation
US5962406A (en) * 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
US5981724A (en) 1991-10-25 1999-11-09 Immunex Corporation DNA encoding CD40 ligand, a cytokine that binds CD40
US5246113A (en) * 1992-02-11 1993-09-21 Riverwood International Corporation Carrier for stacked articles
US5683693A (en) 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
CN1232402A (zh) 1996-10-11 1999-10-20 布里斯托尔-迈尔斯斯奎布公司 免疫调节的方法和组合物
WO1999023229A1 (en) * 1997-10-30 1999-05-14 Cornell Research Foundation, Inc. A method of inhibiting an immune response to a recombinant vector
EP2101877B1 (en) 2006-12-28 2013-06-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo
ES2589134T3 (es) 2012-07-18 2016-11-10 Apogenix Ag Inhibidores de la ruta de señalización de CD95 para el tratamiento de MDS
JP2014184804A (ja) 2013-03-22 2014-10-02 Toyota Motor Corp 車両用動力伝達装置の制御装置
EP3076179A1 (en) 2015-03-30 2016-10-05 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Diagnosis and treatment of low grade gliomas
WO2017044752A1 (en) * 2015-09-10 2017-03-16 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Anti-fibrotic effect of cd70
MX2021011608A (es) 2019-03-29 2021-12-10 Myst Therapeutics Llc Metodos ex vivo para producir celulas t terapeuticas y composiciones y metodos afines.
JP2023504042A (ja) 2019-11-27 2023-02-01 ミスト セラピューティクス リミテッド ライアビリティ カンパニー 調節物質を使用した腫瘍反応性ｔ細胞組成物の生成方法
BR112022016490A2 (pt) 2020-02-27 2022-10-11 Myst Therapeutics Llc Métodos para enriquecimento ex vivo e expansão de células t reativas tumorais e composições relacionadas das mesmas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3149289A (en) * 1988-03-18 1989-09-21 Rockefeller University, The Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor
US5057604A (en) * 1988-08-03 1991-10-15 Washington University Novel monoclonal antibodies
US5204445A (en) * 1988-10-03 1993-04-20 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding
US5169930A (en) * 1990-01-05 1992-12-08 La Jolla Cancer Research Foundation Fibronectin receptor
WO1991019511A1 (en) * 1990-06-18 1991-12-26 The General Hospital Corporation CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS

Also Published As

Publication number Publication date
EP0595659A3 (en) 1995-01-11
FI934751A0 (fi) 1993-10-27
NO933860L (no) 1994-05-02
IL107432A0 (en) 1994-01-25
CA2109398A1 (en) 1994-05-01
NO933860D0 (no) 1993-10-27
AU5034493A (en) 1994-05-12
MX9306682A (es) 1994-04-29
JPH072899A (ja) 1995-01-06
EP0595659A2 (en) 1994-05-04

Similar Documents

Publication Publication Date Title
DE69409487T2 (de) Betriebssystem mit objektorientierter druckschnittstelle
DE68927219D1 (de) Telekommunikationssystem mit von dem Teilnehmer gesteuerter Merkmalveränderung
DE3887682D1 (de) Vielfarben-Anzeigevorrichtung.
DE68918595T2 (de) Matrix-septum.
FI934751A (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
FI955646A (fi) Ligandeja FLT3-reseptoreita varten
DE69420067D1 (de) Bürstendichtung mit ausgehöhlter Rückplatte
DE69623863D1 (de) Rückstrahlungssystem mit Doppelmodulation
FI925471A (fi) Hengityssuojain, jossa on näytt¦yksikk¦
NO911234L (no) Innsmekkbar aktivatorhendel.
DE69424250T2 (de) Gradiertes Katalysator System
IT8905203A0 (it) Innesto particolarmente per frizione idraulica a liquido viscoso.
DE68908113D1 (de) Head-up anzeigesysteme.
DE69331435T2 (de) Fernmeldesystem mit verbesserter Rekonfigurationsfähigkeit
DE69010788D1 (de) Räumliche Lichtmodulatoren.
DE59101241D1 (de) Warenführungssystem.
DE3877953T2 (de) Behaelter mit elastischem schnappscharnier.
ITMI922876A1 (it) Zaino a tracolla provvisto di schienale anatomicamente adattabile
DE59406954D1 (de) Sitzbefestigung
FR2679048B1 (fr) Modulateur electrooptique.
DE68922692D1 (de) Matrixverbindungssystem.
ATE104691T1 (de) Dispersionsfarbstoffe.
DE68920580D1 (de) Anzeigesystem mit direktem Farbmodus.
DK37490D0 (da) Samlebindsrygaggregat
DE59307718D1 (de) Geschiebepassung mit Scharnierbewegung

Legal Events

Date Code Title Description
FD Application lapsed